case_images: PMC5039347_01
case_images: 2nd case a) at presentation, b) postoperative
case_images: OC-06-10-g-002.jpg
case_images: PMC5039347_01_OC-06-10-g-002.jpg
case_images: F2
case_images: The 2nd case was an 11-year-old child with steroid induced glaucoma with an inferotemporal FP7 implant operated elsewhere, that extruded two months after surgery (Figure 2a (Fig. 2)). Reimplantation with smaller FP8 implant (Figure 2b (Fig. 2)) was performed one month later in the superotemporal quadrant.
case_images: PMC5039347_02
case_images: 6th case a) at presentation, b) postoperative
case_images: OC-06-10-g-003.jpg
case_images: PMC5039347_02_OC-06-10-g-003.jpg
case_images: F3
case_images: AGV implantation in his only seeing right eye, following which he experienced five episodes of implant exposure, managed by various combinations of patch grafts including amniotic membrane, conjunctival autograft, and buccal mucosal graft at multiple centers. At presentation to us, the body of the AGV was totally extruded (Figure 3a (Fig. 3)) along with the buccal mucosal flap overlying it with anterior chamber exudates, resolving vitreous hemorrhage and hypotony. Postoperatively, the implant was stable (Figure 3b (Fig. 3)) with the IOP under control with one antiglaucoma medication till the final follow-up.